117 related articles for article (PubMed ID: 6740247)
1. Opsonic and antibody responses to pneumococcal polysaccharide types 6A, 19F and 23F after vaccination of immunocompromised patients.
Braconier JH; Pedersen FK; Odeberg H; Rosén C
Scand J Infect Dis; 1984; 16(2):161-7. PubMed ID: 6740247
[TBL] [Abstract][Full Text] [Related]
2. Immune responses of splenectomized trauma patients to the 23-valent pneumococcal polysaccharide vaccine at 1 versus 7 versus 14 days after splenectomy.
Shatz DV; Schinsky MF; Pais LB; Romero-Steiner S; Kirton OC; Carlone GM
J Trauma; 1998 May; 44(5):760-5; discussion 765-6. PubMed ID: 9603075
[TBL] [Abstract][Full Text] [Related]
3. Antibody response and opsonization afer pneumococcal vaccination in splenectomized children and healthy persons.
Johansen KS; Pedersen FK
Acta Pathol Microbiol Immunol Scand C; 1982 Oct; 90(5):265-70. PubMed ID: 7180463
[TBL] [Abstract][Full Text] [Related]
4. IgG subclass response and opsonization of Streptococcus pneumoniae after vaccination of healthy adults.
Bardardottir E; Jonsson S; Jonsdottir I; Sigfusson A; Valdimarsson H
J Infect Dis; 1990 Aug; 162(2):482-8. PubMed ID: 2373875
[TBL] [Abstract][Full Text] [Related]
5. Serum opsonic activity after pneumococcal vaccination in splenectomized individuals as measured by a nitroblue tetrazolium (NBT) reduction micromethod.
Urban T; Linné T; Jakobsson B; Jarstrand C
J Clin Lab Immunol; 1986 Jan; 19(1):49-52. PubMed ID: 3701833
[TBL] [Abstract][Full Text] [Related]
6. Serum antibody and opsonic responses to vaccination with pneumococcal capsular polysaccharide in normal and splenectomized children.
Giebink GS; Foker JE; Kim Y; Schiffman G
J Infect Dis; 1980 Mar; 141(3):404-12. PubMed ID: 6988526
[No Abstract] [Full Text] [Related]
7. Prevention of pneumococcal bacteremia by immunization with type 6 pneumococcal capsular polysaccharide vaccine in splenectomized rats.
Iinuma H; Okinaga K
J Infect Dis; 1989 Jul; 160(1):66-75. PubMed ID: 2732517
[TBL] [Abstract][Full Text] [Related]
8. Cross-reacting opsonic antibodies to clinically important pneumococcal serotypes after pneumococcal vaccination.
Braconier JH; Myhre EB; Odeberg H
Eur J Clin Microbiol; 1983 Oct; 2(5):453-8. PubMed ID: 6641723
[TBL] [Abstract][Full Text] [Related]
9. The antibody response after immunization with pneumococcal polysaccharide vaccine in splenectomized mice: the effect of re-immunization with pneumococcal antigens.
Aaberge IS; Løvik M
APMIS; 1996 Apr; 104(4):307-17. PubMed ID: 8645471
[TBL] [Abstract][Full Text] [Related]
10. Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly.
Sankilampi U; Honkanen PO; Bloigu A; Herva E; Leinonen M
J Infect Dis; 1996 Feb; 173(2):387-93. PubMed ID: 8568300
[TBL] [Abstract][Full Text] [Related]
11. Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumoniae.
Nahm MH; Olander JV; Magyarlaki M
J Infect Dis; 1997 Sep; 176(3):698-703. PubMed ID: 9291318
[TBL] [Abstract][Full Text] [Related]
12. Antibody response to pneumococcal vaccine in splenectomized adults and adolescents.
Pedersen FK; Nielsen JL; Ellegaard J
Acta Pathol Microbiol Immunol Scand C; 1982 Oct; 90(5):257-63. PubMed ID: 6891169
[TBL] [Abstract][Full Text] [Related]
13. Increased serum opsonic activity and antibody concentration in patients with sickle cell disease after pneumococcal polysaccharide immunization.
Chudwin DS; Wara DW; Matthay KK; Caulfield MH; Schiffmann G; Mentzer WC; Ammann AJ
J Pediatr; 1983 Jan; 102(1):51-4. PubMed ID: 6848728
[TBL] [Abstract][Full Text] [Related]
14. Antibody responses of splenectomized patients with non-Hodgkin's lymphoma to immunization with polyvalent pneumococcal vaccines.
Petrasch S; Kühnemund O; Reinacher A; Uppenkamp M; Reinert R; Schmiegel W; Lütticken R; Brittinger G
Clin Diagn Lab Immunol; 1997 Nov; 4(6):635-8. PubMed ID: 9384280
[TBL] [Abstract][Full Text] [Related]
15. Type-specific anti-pneumococcal antibody subclass response to vaccination after splenectomy with special reference to lymphoma patients.
Grimfors G; Björkholm M; Hammarström L; Askergren J; Smith CI; Holm G
Eur J Haematol; 1989 Nov; 43(5):404-10. PubMed ID: 2612613
[TBL] [Abstract][Full Text] [Related]
16. IgG subclass antibody responses to pneumococcal polysaccharide vaccine in splenectomized, otherwise normal, individuals.
Aaberge IS; Michaelsen TE; Heier HE
Scand J Immunol; 1990 Jun; 31(6):711-6. PubMed ID: 2356437
[TBL] [Abstract][Full Text] [Related]
17. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma.
Landgren O; Björkholm M; Konradsen HB; Söderqvist M; Nilsson B; Gustavsson A; Axdorph U; Kalin M; Grimfors G
J Intern Med; 2004 Jun; 255(6):664-73. PubMed ID: 15147530
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of antibody responses to pneumococcal vaccines with ELISA and opsonophagocytic assay.
Kim KH; Seoh JY
J Korean Med Sci; 1999 Oct; 14(5):475-9. PubMed ID: 10576141
[TBL] [Abstract][Full Text] [Related]
19. Natural and vaccine-related immunity to Streptococcus pneumoniae.
Musher DM; Chapman AJ; Goree A; Jonsson S; Briles D; Baughn RE
J Infect Dis; 1986 Aug; 154(2):245-56. PubMed ID: 3722865
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal conjugate vaccination in toddlers: mucosal antibody response measured as circulating antibody-secreting cells and as salivary antibodies.
Nieminen T; Käyhty H; Leroy O; Eskola J
Pediatr Infect Dis J; 1999 Sep; 18(9):764-72. PubMed ID: 10493335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
